Description: The MS community needs your help to test first-of-a kind therapy for PPMS and RMS to determine its potential to both reduce relapses as well as slow the progression of the disease. Roche is committed to developing cutting-edge treatments to improve the lives of people living with multiple sclerosis.
The MS community needs your help to test first-of-a kind therapy for PPMS and RMS to determine its potential to both reduce relapses as well as slow the progression of the disease.
To learn more about our clinical studies, click below:
Roche is committed to developing cutting-edge treatments to improve the lives of people living with multiple sclerosis. By participating in these studies, you may help create a brighter future for people living with RMS and PPMS.